Pharmaceutical manufacturing companies operating in Syria have warned of a potential loss of certain medications in the market, following the announcement by currency exchange companies about their readiness to finance traders and industrialists with foreign currency through immediate sales of the US dollar at a price of 3,290 Syrian pounds. The dollar exchange rate in the black market exceeds 3,400 pounds, while the "Central Bank of Syria" sets the official dollar rate at 2,512 pounds. Private pharmaceutical manufacturing companies stated that the rising cost of funding for industry supplies, especially in the pharmaceutical sector, contributes to the unavailability of some types of medicines in the local market due to increased production costs, according to the local newspaper "Al-Watan." They emphasized that "day by day, the prices of raw materials are increasing, and production costs are rising, putting the pharmaceutical industry in a difficult situation, in addition to banks delaying in repaying bills."